Results 101 to 110 of about 1,321,964 (375)

Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment [PDF]

, 1996
BACKGROUND/AIMS: The role of cellular immunity in the clearance of hepatitis C virus after interferon therapy has not yet been elucidated. Here, we analyzed the T cell response to peptides from hepatitis C virus E1 protein in untreated and interferon ...
Borras-Cuesta, F. (Francisco), Civeira, M.P. (María Pilar), Garcia, N. (Nicolás), Jauregui, J.I. (Javier Ignacio), Lasarte, J.J. (Juan José), Prieto, J. (Jesús), Sarobe, P. (Pablo)   +6 more
core   +1 more source

An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases

Hepatology, 2011
The standard of care (SOC) therapy for patients with chronic hepatitis C virus (HCV) infection has been the use of both peginterferon (PegIFN) and ribavirin (RBV).
M. Ghany, D. Nelson, D. Strader, David L. Thomas, L. Seeff   +4 more
semanticscholar   +1 more source

Pityriasis rosea in chronic hepatitis C

Balkan Medical Journal, 2014
Dear Editor, The report on “Pityriasis rosea (PR) in chronic hepatitis C” is very interesting (1). Guner et al. (1) noted that this is “the first case of PR found in a patient with chronic hepatitis C while receiving Pegylated interferon (PEG-IFN) alpha 2b and ribavirin.” In fact, the cause of the existence of PR in hepatitis C is an interesting ...
Güner R., Keske Ş., Hasanoğlu İ., Taşyaran M.A.   +3 more
openaire   +6 more sources

Anisotropic Surface Microrollers for Endovascular Navigation: A Computational Analysis with a Case Study in Hepatic Perfusion

Advanced Theory and Simulations, EarlyView.
Computational fluid dynamics analyses assess the upstream locomotion performance of anisotropic microrollers with varying height‐to‐width ratios. Observing their successful upstream locomotion in veins, their performance in hepatic circulation is investigated for treating primary liver cancer.
Burak Arslan, Ugur Bozuyuk, Kıvanç Görgülü, Erdost Yildiz, Hakancan Ozturk, Lucia Liotta, Volker Heinemann, Hana Algül, Metin Sitti   +8 more
wiley   +1 more source

Identification of Histopathologic Criteria to Differentiate Autoimmune Hepatitis (AIH) from Chronic Viral Hepatitis (B, C) in Liver Biopsy Samples

مجله دانشکده پزشکی اصفهان, 2017
Background: Chronic hepatitis is a common disease in the community. Differential diagnosis of hepatitis is very important in the treatment of this disease; as applying the wrong treatment method can lead to reinforcement and aggravate.
Mohammadhossein Sanei, Azar Naimi, Pardis Nematolahy, Yaser Moein   +3 more
doaj  

A Bayesian Evidence Synthesis Approach to Estimate Disease Prevalence in Hard-To-Reach Populations: Hepatitis C in New York City [PDF]

arXiv, 2018
Existing methods to estimate the prevalence of chronic hepatitis C (HCV) in New York City (NYC) are limited in scope and fail to assess hard-to-reach subpopulations with highest risk such as injecting drug users (IDUs). To address these limitations, we employ a Bayesian multi-parameter evidence synthesis model to systematically combine multiple sources
arxiv  

The Treatment Cascade for Chronic Hepatitis C Virus Infection in the United States: A Systematic Review and Meta-Analysis

PLoS ONE, 2014
Background Identifying gaps in care for people with chronic hepatitis C virus (HCV) infection is important to clinicians, public health officials, and federal agencies.
B. Yehia, Asher J. Schranz, C. Umscheid, V. Lo Re   +3 more
semanticscholar   +1 more source

Viral‐Mediated Connexin 26 Expression Combined with Dexamethasone Rescues Hearing in a Conditional Gjb2 Null Mice Model

Advanced Science, EarlyView.
AAV2.7m8 serotype combined with the gfaABC1D promoter targets infection of supporting cells (SCs). AAV2.7m8‐gfaABC1D‐Gjb2 administration to mice results in excessive immune responses. The combination of AAV2.7m8‐gfaABC1D‐Gjb2 with dexamethasone (DEX) shows a synergistic effect and enhances the gene therapy effect in a conditional Cx26 null mice model ...
Xiaohui Wang, Li Zhang, Sen Chen, Le Xie, Yue Qiu, Chenyang Kong, Ge Yin, Weijia Kong, Yu Sun   +8 more
wiley   +1 more source

Optimizing Interferon Alfa Based Therapy for Chronic Hepatitis C [PDF]

, 2011
The hepatitis C virus was first discovered in 1989 as the major cause of chronic non-A non-B hepatitis. The hepatitis C virus is a single stranded RNA virus that belongs to the family of flaviviruses.
Roomer, R. (Robert)
core  

Antimitochondrial antibody -M2 positive autoimmune hepatitis during standard of care for chronic hepatitis C. [PDF]

, 2012
The current standard of care (SoC) for chronic hepatitis C, i.e. the combination of a pegylated-interferon (PEG-IFN) with ribavirin (RBV), may activate underlying autoimmune conditions.
ALESSI, Nicola, CABIBI, Daniela, MACALUSO, Fabio Salvatore   +2 more
core   +1 more source